Evidence map›Paper›PMID 31316315›Full record

ArticleBreast care (Basel, Switzerland)2019

Autologous Lipotransfer - Daily Therapeutic Practice in Breast Cancer: An Intergroup Analysis Encompassing NOGGO, WSG, GBG, AWO Gyn and DGPRÄC.

Aylin Kümmel, Sherko Kümmel, Jens-Uwe Blohmer, Andree Faridi, Ulrike Nitz, Sibylle Loibl, Uwe von Fritschen, Daniela Rezek, Friederike Hagemann, Johannes Holtschmidt and 2 more

Abstract read
In one paragraph

Article in Breast care (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Aylin KümmelBreast Unit, Kliniken Essen Mitte, Essen, Germany.
Sherko KümmelBreast Unit, Kliniken Essen Mitte, Essen, Germany.
Jens-Uwe BlohmerDepartment of Obstetrics and Gynecology, Breast Unit, Berlin, Germany.
Andree FaridiBrustzentrum Universitätsklinik Bonn, Universitätskliniken Bonn, Bonn, Germany.
Ulrike NitzBrustzentrum Niederrhein, Evangelisches Bethesda-Krankenhaus, Mönchengladbach, Germany.
Sibylle LoiblGerman Breast Group, GBG Forschungs GmbH, Neu-Isenburg, Germany.
Uwe von FritschenPlastische und Ästhetische Chirurgie, HELIOS Klinikum Emil von Behring, Berlin, Germany.
Daniela RezekBrustzentrum, Marien-Hospital, Wesel, Germany.
Friederike HagemannBreast Unit, Kliniken Essen Mitte, Essen, Germany.
Johannes HoltschmidtBreast Unit, Kliniken Essen Mitte, Essen, Germany.
Suzan BotzenhardtBreast Unit, Kliniken Essen Mitte, Essen, Germany.
Mattea ReinischBreast Unit, Kliniken Essen Mitte, Essen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAutologous fat transfer in breast reconstruction has become increasingly important in breast reconstructive surgery. Although the indication to obtain fat, the various operative procedures, and the risks for the patient have been addressed in a large number of studies, detailed information on the everyday use of autologous lipotransfer in breast units in Germany is still lacking.

methodsThe objective of the study was to obtain primary data on the use of autologous lipotransfer to treat breast cancer patients in Germany and to determine measures for quality assurance in the daily practice. An online questionnaire concerning breast cancer and lipofilling was sent to specialists in gynecology and plastic surgery.

resultsTwo-thirds of the specialists who responded to the questionnaire use autologous lipotransfer for breast reconstruction and did not report an increase of local recurrence following lipotransfer. There were only small differences between gynecologists and plastic surgeons regarding the procedure and indication for lipotransfer. The method is highly accepted by patients and physicians, and both gynecologists and plastic surgeons rated the improvement achieved through lipofilling as 'high'.

conclusionsThe lack of randomized controlled data, especially in high-risk patients, demonstrates the necessity for a registry study on this topic. Our survey describes, in detail, the indications for lipofilling as well as its appropriate application in breast cancer patients in Germany and may thereby reduce the present therapeutic uncertainties.

Indexed as

Autologous lipotransferBreast cancerLipofillingPlastic-reconstructive surgery fat grafting

Identifiers

PMID31316315
PMCPMC6600037

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.